A Hemoglobinopathy That Produces an Array of Different Hemoglobin A1c Values.

IF 1.3 Q4 HEMATOLOGY
Journal of hematology Pub Date : 2024-06-01 Epub Date: 2024-06-28 DOI:10.14740/jh1268
Maximo J Marin, Bremansu Osa-Andrews, Patrick A Maher, Clive Wasserfall, William E Winter, Ashraf B Muzwagi, Neil S Harris
{"title":"A Hemoglobinopathy That Produces an Array of Different Hemoglobin A1c Values.","authors":"Maximo J Marin, Bremansu Osa-Andrews, Patrick A Maher, Clive Wasserfall, William E Winter, Ashraf B Muzwagi, Neil S Harris","doi":"10.14740/jh1268","DOIUrl":null,"url":null,"abstract":"<p><p>Hemoglobin A1c (HbA1c) refers to non-enzymatically glycated hemoglobin and reflects the patient's glycemic status over approximately 3 months. An elevated HbA1c over 6.5% National Glycohemoglobin Standardization Program (NGSP) (48 mmol/mol the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)) can be used to diagnose diabetes mellitus. In our laboratory, HbA1c is determined by ion-exchange chromatography which has the advantage of detecting common Hb variants such as Hb S, C, E and D without adversely affecting the HbA1c determination. Certain homozygous or compound heterozygous hemoglobinopathies such as homozygous sickle disease and Hb SC disease can significantly lower the HbA1c by reducing red cell lifespan. Occasionally however, rare and mostly benign hemoglobinopathies can interfere with this technique resulting in an apparent elevation of HbA1c in an otherwise non-diabetic patient. In this report, we describe such a hemoglobinopathy termed Hb Wayne that resulted in a significant HbA1c elevation in a normoglycemic individual. HbA1c was determined by multiple methods including immunoassay, a modified capillary electrophoresis and an alternative ion-exchange system. These techniques yielded significantly lower A1c results, more in keeping with the patient's clinical background. The alternative ion-exchange system resulted in a low A1c that was qualified by warning flags on the chromatogram that indicated the result was not reportable. The hemoglobinopathy in question, Hb Wayne, is a frameshift mutation in the alpha globin gene that results in an extended alpha globin polypeptide that can form two variants Hb Wayne I and Wayne II. Hb Wayne is a clinically silent asymptomatic disorder with no hematologic consequences. The artifactual elevation of HbA1c is, in contrast, very significant because it may result in a misdiagnosis of diabetes mellitus leading to unnecessary treatment. In this report, we compare our findings with other descriptions of Hb Wayne in the literature and corroborate a number of previous observations and conclusions.</p>","PeriodicalId":15964,"journal":{"name":"Journal of hematology","volume":"13 3","pages":"99-103"},"PeriodicalIF":1.3000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11236361/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of hematology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14740/jh1268","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/28 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Hemoglobin A1c (HbA1c) refers to non-enzymatically glycated hemoglobin and reflects the patient's glycemic status over approximately 3 months. An elevated HbA1c over 6.5% National Glycohemoglobin Standardization Program (NGSP) (48 mmol/mol the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)) can be used to diagnose diabetes mellitus. In our laboratory, HbA1c is determined by ion-exchange chromatography which has the advantage of detecting common Hb variants such as Hb S, C, E and D without adversely affecting the HbA1c determination. Certain homozygous or compound heterozygous hemoglobinopathies such as homozygous sickle disease and Hb SC disease can significantly lower the HbA1c by reducing red cell lifespan. Occasionally however, rare and mostly benign hemoglobinopathies can interfere with this technique resulting in an apparent elevation of HbA1c in an otherwise non-diabetic patient. In this report, we describe such a hemoglobinopathy termed Hb Wayne that resulted in a significant HbA1c elevation in a normoglycemic individual. HbA1c was determined by multiple methods including immunoassay, a modified capillary electrophoresis and an alternative ion-exchange system. These techniques yielded significantly lower A1c results, more in keeping with the patient's clinical background. The alternative ion-exchange system resulted in a low A1c that was qualified by warning flags on the chromatogram that indicated the result was not reportable. The hemoglobinopathy in question, Hb Wayne, is a frameshift mutation in the alpha globin gene that results in an extended alpha globin polypeptide that can form two variants Hb Wayne I and Wayne II. Hb Wayne is a clinically silent asymptomatic disorder with no hematologic consequences. The artifactual elevation of HbA1c is, in contrast, very significant because it may result in a misdiagnosis of diabetes mellitus leading to unnecessary treatment. In this report, we compare our findings with other descriptions of Hb Wayne in the literature and corroborate a number of previous observations and conclusions.

血红蛋白病会产生一系列不同的血红蛋白 A1c 值。
血红蛋白 A1c(HbA1c)是指非酶糖化血红蛋白,反映患者约 3 个月的血糖状况。HbA1c 升高超过 6.5% 国家糖化血红蛋白标准化计划 (NGSP)(48 mmol/mol,国际临床化学和实验室医学联合会 (IFCC))可用于诊断糖尿病。在我们的实验室中,HbA1c 是通过离子交换色谱法测定的,其优点是可以检测到常见的 Hb 变异体,如 Hb S、C、E 和 D,而不会对 HbA1c 的测定产生不利影响。某些同种或复合杂合血红蛋白病,如同种镰状血红蛋白病和 Hb SC 病,可通过缩短红细胞寿命而显著降低 HbA1c。然而,罕见的良性血红蛋白病偶尔也会干扰这一技术,导致原本非糖尿病患者的 HbA1c 明显升高。在本报告中,我们描述了一种被称为 Hb Wayne 的血红蛋白病,它导致一名血糖正常者的 HbA1c 明显升高。HbA1c 是通过多种方法测定的,包括免疫测定法、改良毛细管电泳法和另一种离子交换系统。这些技术得出的 A1c 结果明显较低,更符合患者的临床背景。替代离子交换系统得出的 A1c 值较低,但色谱图上的警告标志表明该结果不可报告。Hb Wayne 血红蛋白病是α-球蛋白基因的框架移位突变,导致α-球蛋白多肽延长,可形成两种变体 Hb Wayne I 和 Wayne II。Hb Wayne 是一种临床上无症状的沉默性疾病,对血液学没有影响。相反,HbA1c 的人为升高却非常重要,因为它可能导致糖尿病的误诊,从而导致不必要的治疗。在本报告中,我们将我们的研究结果与文献中关于 Hb Wayne 的其他描述进行了比较,并证实了之前的一些观察结果和结论。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of hematology
Journal of hematology HEMATOLOGY-
自引率
0.00%
发文量
29
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信